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Abstract: Due to increasing antibiotic resistance, the application of antimicrobial photodynamic therapy
(aPDT) is gaining increasing popularity in dentistry. The aim of this study was to investigate the an-
timicrobial effects of aPDT using visible light (VIS) and water-filtered infrared-A (wIRA) in combination
with a Hypericum perforatum extract on in situ oral biofilms. The chemical composition of H. perforatum
extract was analyzed using ultra-high-performance liquid chromatography coupled with high resolution
mass spectrometry (UPLC-HRMS). To obtain initial and mature oral biofilms in situ, intraoral devices
with fixed bovine enamel slabs (BES) were carried by six healthy volunteers for two hours and three days,
respectively. The ex situ exposure of biofilms to VIS + wIRA (200 mWcm−2) and H. perforatum (32
mg ml−1, non-rinsed or rinsed prior to aPDT after 2-min preincubation) lasted for five minutes. Biofilm
treatment with 0.2% chlorhexidine gluconate solution (CHX) served as a positive control, while untreated
biofilms served as a negative control. The colony-forming units (CFU) of the aPDT-treated biofilms were
quantified, and the surviving microorganisms were identified using MALDI-TOF biochemical tests as well
as 16 S rDNA-sequencing. We could show that the H. perforatum extract had significant photoactivation
potential at a concentration of 32 mg ml−1. When aPDT was carried out in the presence of H. perfora-
tum, all biofilms (100%) were completely eradicated (p = 0.0001). When H. perforatum was rinsed off
prior to aPDT, more than 92% of the initial viable bacterial count and 13% of the mature oral biofilm
were killed. Overall, the microbial composition in initial and mature biofilms was substantially altered
after aPDT, inducing a shift in the synthesis of the microbial community. In conclusion, H. perforatum-
mediated aPDT using VIS + wIRA interferes with oral biofilms, resulting in their elimination or the
substantial alteration of microbial diversity and richness. The present results support the evaluation of
H. perforatum-mediated aPDT for the adjunctive treatment of biofilm-associated oral diseases.
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Antimicrobial photoinactivation 
Using Visible Light plus Water-
filtered infrared-A (ViS + wiRA) 
and Hypericum Perforatum Modifies 
In Situ Oral Biofilms
Andreas Vollmer1, Ali Al-Ahmad1, Aikaterini Argyropoulou2, thomas thurnheer  3, 
elmar Hellwig1, thomas Attin3, Kirstin Vach4, Annette Wittmer5, Kerry ferguson6, 
Alexios Leandros Skaltsounis2 & Lamprini Karygianni  3*
Due to increasing antibiotic resistance, the application of antimicrobial photodynamic therapy (apDt) 
is gaining increasing popularity in dentistry. the aim of this study was to investigate the antimicrobial 
effects of aPDT using visible light (VIS) and water-filtered infrared-A (wIRA) in combination with a 
Hypericum perforatum extract on in situ oral biofilms. The chemical composition of H. perforatum 
extract was analyzed using ultra-high-performance liquid chromatography coupled with high resolution 
mass spectrometry (UPLC-HRMS). To obtain initial and mature oral biofilms in situ, intraoral devices 
with fixed bovine enamel slabs (BES) were carried by six healthy volunteers for two hours and three 
days, respectively. the ex situ exposure of biofilms to VIS + wIRA (200 mWcm−2) and H. perforatum 
(32 mg ml−1, non-rinsed or rinsed prior to aPDT after 2-min preincubation) lasted for five minutes. 
Biofilm treatment with 0.2% chlorhexidine gluconate solution (CHX) served as a positive control, 
while untreated biofilms served as a negative control. The colony-forming units (CFU) of the aPDT-
treated biofilms were quantified, and the surviving microorganisms were identified using MALDI-TOF 
biochemical tests as well as 16 S rDNA-sequencing. We could show that the H. perforatum extract had 
significant photoactivation potential at a concentration of 32 mg ml−1. When apDt was carried out in 
the presence of H. perforatum, all biofilms (100%) were completely eradicated (p = 0.0001). When H. 
perforatum was rinsed off prior to aPDT, more than 92% of the initial viable bacterial count and 13% of 
the mature oral biofilm were killed. Overall, the microbial composition in initial and mature biofilms 
was substantially altered after apDt, inducing a shift in the synthesis of the microbial community. in 
conclusion, H. perforatum-mediated apDt using ViS + wIRA interferes with oral biofilms, resulting in 
their elimination or the substantial alteration of microbial diversity and richness. the present results 
support the evaluation of H. perforatum-mediated aPDT for the adjunctive treatment of biofilm-
associated oral diseases.
The growing ineffectiveness of several conventional antimicrobial agents for the treatment of various 
biofilm-associated infections has been identified1,2. Interestingly, it has been shown that biofilm inhabitants have 
an enhanced resistance of up to 1,000 times against antibiotics compared with their planktonic counterparts3,4. 
Recently, aPDT was successfully applied to treat biofilm-associated oral infections such as caries, periodontitis 
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and periimplantitis5. Thus, aPDT-driven oral decontamination can serve as an adjunct method to traditional 
dental treatment approaches.
The majority of aPDT protocols involve the combined application of various harmless light sources and 
mostly cationic local photosensitizing agents such as methylene blue (MB), toluidine blue O (TB), indocyanine 
green (ICG) and chlorine e6 (Ce6)6–8. Regarding the light sources, the combination of visible light (VIS) and 
water-filtered infrared-A (wIRA) has been shown to increase in situ temperature and perfusion levels, inducing 
wound healing at higher oxygen partial tissue pressure. Interestingly, VIS + wIRA correlates with significant pain 
reduction9. Another advantage of wIRA is the induction of low thermal stress via sufficient tissue penetration, 
which protects the external tissue layers10,11. Already-tested photosensitizers such as TB and Ce6 have shown 
enhanced antimicrobial activity in combination with aPDT against monospecies and multispecies biofilms12–15. 
Recently, VIS + wIRA in combination with TB or Ce6 has proven to be a potent alternative treatment against 
in situ supragingival and subgingival multispecies biofilms16,17.
The photodynamic properties of Hypericum perforatum (St. John’s Wort) have been well known for years 
now18,19. Indeed, it is one of the most commonly-investigated medicinal plants of the last two decades20–22. To 
date, H. perforatum has been widely used for topical application to skin prior to aPDT to accelerate chronic 
wound healing18. H. perforatum can also be used as an antidepressive substance23,24. Due to its additional favora-
ble anti-oxidant, anti-inflammatory, anti-cancer and antimicrobial properties, H. perforatum is responsible for 
the enhanced differentiation of keratinocytes18. Interestingly, its high biocompatibility could lead it to play an 
outstanding role in aPDT application in the dental field25. Among H. perforatum’s main components, lipophilic 
hyperforin and hypericin seem to be the most active substances26,27. Favorably, H. perforatum shows no muta-
genic potential and binding to DNA molecules28.
Despite their excellent properties, common photosensitizers such as TB or Ce6 fail to efficiently penetrate 
into extracellular DNA within the polysaccharide matrix to eradicate the pathogens situated in the deepest bio-
film layers29. In this context, the photodynamic properties of H. perforatum prompted the idea that aPDT using 
VIS + wIRA and H. perforatum could be a promising alternative method for treating multispecies oral biofilms. 
Considering that the development of oral diseases such as periodontitis and periimplantitis relates to pathologi-
cal shifts in oral biofilms, modifying biofilm composition and thus diversity could positively affect the treatment 
impact23.
The aim of the present study was to investigate the survival and diversity of microorganisms within ini-
tial and mature oral biofilms after the application of aPDT using VIS + wIRA and H. perforatum as a photo-
sensitizer. For this approach, we cultivated oral biofilms in situ onto bovine enamel samples (Fig. 1) for two 
hours (h) and three days (d), respectively. The in situ biofilms were then treated with the photosensitizer H. 
perforatum and VIS + wIRA ex vivo aPDT (Fig. 2). To our knowledge, alteration in biofilm diversity follow-
ing aPDT by VIS + wIRA and H. perforatum has not been studied to date. The null hypothesis was that aPDT 
using VIS + wIRA and H. perforatum would not eliminate oral biofilms or modify the composition of in situ oral 
biofilms.
Results
chemical composition of the H. perforatum extract. A rapid and accurate method was developed, 
aiming to detect the major active compounds in the H. perforatum extract, as described elsewhere30. For the 
LC-HRMS, an Orbitrap high resolution mass analyzer was used in negative ionization mode. Peaks were iden-
tified by comparing the retention times and HRMS data of the compounds with already-published data31,32 
and natural product databases (PubChem, ChemSpider). The extract of H. perforatum contains a wide range 
of constituents (Table 1, Fig. 3). All of the detected compounds along with their names, Rt (min), molecular 
formula, theoretical and experimental m/z, mass difference (ppm) and RDBeq (Relative Double Bond equiva-
lent) value are summarized in Table 1, whereby a total of sixteen secondary compounds were detected. Phenolic 
Figure 1. Individual upper jaw acrylic splint. The BES were attached at the front (f), in the middle (m) and at 
the back (b) on the right (R) and left (L) sides of the splint. Both BES downward-facing surface margins were 
covered with silicon, while only their upward-facing surfaces remained exposed to the buccal tooth surfaces 
during the experiments.
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acids, flavonoids, biflavones, phloroglucinols and naphthodianthrones were identified. Naphthodianthrones are 
characteristic compounds of the genus Hypericum. In the studied extract, hypericin and pseudohypericin were 
detected at Rt 22.74 and 23.27 min, respectively. Phloroglucinol – represented by hyperfirin and hyperforin – 
was also identified, as they are considered typical representatives of the genus. Several types of flavonoids – a 
flavonol (quercetin), flavonoid-O-glycosides (isoquercetrin, quercitrin, rutin and skyrin-2-O-glucopyranoside) 
and flavonol galactosides (hyperoside and isoquercitrin) – were identified. Two dimeric types of flavones – I3,II8 
Biapigenin at Rt 11.41 min and amentoflavone at Rt 12.04 min – that are commonly detected in H. perforatum 
were also found in the studied extract. Additionally, various phenolic compounds (quinic acid, chlorogenic acid 
and 3-O-feruloylquinic acid) were detected.
aPDT effects on the viable counts of oral microorganisms at initial adhesion and in mature 
oral biofilms. Figure 4a shows the effects of aPDT using VIS + wIRA and H. perforatum on the log counts 
of the initial and mature oral biofilms after two hours and three days, respectively. The aPDT induced a complete 
eradication of the bacteria (p = 0.0001, Fig. 4a) within the initial biofilms treated with non-rinsed H. perforatum, 
whether followed or not by aPDT, as well as within the CHX-treated initial biofilms. Interestingly, the initial 
biofilms in which H. perforatum was rinsed prior to aPDT exhibited a mean of 0.69 ± 0.95 CFU in the log10 scale 
Figure 2. Graphical scheme depicting aPDT using VIS + wIRA as a light source and H. perforatum as a 
photosensitizer against oral biofilms. The VIS + wIRA with a broadband water-filtered spectrum (570–1400 nm) 
facilitated the excitation of the photosensitizing agent (H. perforatum), triggering its interaction with oxygen 
(O2). ROS were then released, eradicating both planktonic and adherent oral microorganisms.
No Rt (min) EC [M-H]−
Experimental Theoretical
Δm ppm RDBeq Identification of compound[M-H]− m/z
1 0.65 C7H11O6 191.0544 191.0561 −8.730 2.5 Quinic acid
2 6.14 C16H17O9 353.0835 353.0819 −12.363 8.5 Chlorogenic acid
3 7.60 C17H19O9 367.0990 367.0976 −12.137 8.5 3-O-Feruloylquinic acid
4 8.08 C21H19O12 463.0826 463.0823 0.615 12.5 Hyperoside
5 8.16 C21H19O12 463.0828 463.0823 1.077 12.5 Isoquercitrin
6 8.67 C21H19O11 447.0880 447.0874 −12.536 12.5 Isoquercetrin
7 8.72 C21H19O11 447.0877 447.0874 −12.334 12.5 Quercitrin
8 10.09 C15H9O7 301.0319 301.0295 −11.480 11.5 Quercetin
9 10.36 C27H29O16 609.1388 609.1402 −1.965 13.5 Rutin
10 11.41 C30H17O10 537.0762 537.0827 −12.195 22.5 I3,II8 Biapigenin
11 12.04 C30H17O10 537.0757 537.0827 −12.994 22.5 Amentoflavone
12 14.34 C36H27O15 699.1268 699.1355 −12.463 23.5 Skyrin-2-O-glucopyranoside
13 20.37 C30H43O4 467.3113 467.3167 −11.564 9.5 Hyperfirin
14 22.20 C35H51O4 535.3730 535.3793 −11.649 10.5 Hyperforin
15 22.74 C30H15O8 503.0715 503.0714 −11.352 23.5 Hypericin
16 23.27 C30H15O9 519.0661 519.0663 −11.723 23.5 Pseudohypericin
Table 1. Chromatographic and spectrometric characteristics of secondary metabolites identified in H. 
perforatum by LC(ESI-)HRMS.
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(median, 0.25), which is a significantly reduced (p = 0.002) microbial growth compared with the untreated nega-
tive control (mean, 3.81 ± 0.66; median, 3.75).
Figure 4(b,c) displays the microbial growth rates of the three-day-old oral biofilm after the application of 
aPDT. In the presence of H. perforatum, the aerobic and anaerobic microorganisms within the aPDT-treated 
biofilms showed no microbial growth and thus a CFU reduction of 100% (p = 0.0001). With regard to the aer-
obic biofilm bacteria, aPDT following rinsing of H. perforatum (mean, 5.49 ± 0.55; median, 5.52) yielded no 
significant CFU decline compared with the untreated negative control (mean, 6.23 ± 0.38; median, 6.17) and the 
CHX-treated positive control (mean, 5.44 ± 0.71; median, 5.45). Regarding the anaerobic biofilm bacteria, the 
application of aPDT after rinsing H. perforatum (mean, 4.49 ± 1.00; median, 4.64) failed to yield a decrease in 
the log10 CFU counts compared with the negative control (mean, 4.49 ± 1.06; median, 4.32), although it proved 
to be as effective as CHX (mean, 3.19 ± 2.17; median, 4.04). The application of H. perforatum only without sub-
sequent aPDT had no significant effect on either aerobic (mean, 5.02 ± 1.18; median, 5.39) or anaerobic (mean, 
5.33 ± 2.17; median, 4.04) microorganisms.
Shift of bacterial spectrum after the use of apDt against initial microbial adhesion. The com-
position of cultivable bacteria in initial adhesion samples is analyzed in Figs. 5A,B, 6A, and 7A,B. After treatment 
with CHX (positive control) and H. perforatum, whether followed or not by aPDT, all bacteria were eliminated. 
From the original bacterial community in the untreated negative control, a total of 31 different cultivable spe-
cies were isolated and identified, as shown in Fig. 5A. The microbial community was predominated (29%) by 
eight different streptococcal species (Streptococcus mitis/oralis 11%; Streptococcus sanguinis/parasanguinis, 7%; 
Streptococcus salivarius, 4%; Streptococcus australis, 3%; Streptococcus infantis, 3%; Streptococcus gordonii, 1%). 
Different species of the genera Rothia (Rothia dentocariosa, Rothia aeria, Rothia mucilaginosa), Actinomyces 
(Actinomyces odontolyticus, Actinomyces graevenitzii, Actinomyces oris, Actinomyces naeslundii), Neisseria 
(Neisseria flavescens/perflava, Neisseria mucosa, Neisseria macacae) and Gemella (Gemella sanguinis, Gemella 
haemolysans) were found in 22%, 14%, 10% and 5% of the isolated bacteria, respectively. The percentages of all 
other recovered species mainly belonging to the genera Veillonella, Capnocytophaga and Campylobacter, ranged 
from 2–8%. As depicted in Fig. 5B, the aPDT with VIS + wIRA and H. perforatum – which was rinsed prior to 
aPDT – reduced the number of viable bacterial species from 31 to 8, comprising S. sanguinis/parasanguinis (31%), 
S. mitis/oralis (23%), R. mucilaginosa (22%), N. mucosa/macacae (12%) and Granulicatella elegans (12%).
Figure 3. Panel A depicts UPLC-ESI-HRMS chromatogram of the H. perforatum extract. The peaks of 
hyperforin, hypericin and pseudohypericin are marked on the graph. Panel B depicts the absorbance 
spectrum of the fabricated H. perforatum extract including 16% alcohol. The concentration of H. perforatum 
was 32 mg ml−1. The measurement of the spectrum was conducted using a Tecan Infinite 200 reader (Tecan, 
Crailsheim, Germany).
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In the presence of reduced microbial richness, the species diversity of the surviving bacteria among the 
probands was also strongly affected. The most prevalent species in the untreated control group were Streptococcus 
mitis/oralis, R. dentocariosa and Veillonella parvula/dispar (detected in five volunteers), followed by A. odontol-
yticus and R. aeria (retrieved from four volunteers). All other species were detected in three volunteers or fewer. 
After pre-treatment with H. perforatum, rinsing and subsequent aPDT with VIS + wIRA, no cultivable bacteria 
were detected in four of the volunteers. The two remaining positive samples were mainly comprised of S. san-
guinis/parasanguinis and G. elegans, whereas seven different species were only detectable in the second volunteer.
Figure 4. Boxplots of CFU counts, demonstrating the photodynamic efficiency (aPDT using VIS + wIRA and 
H. perforatum) against oral microorganisms after two-hour (2 h) initial adhesion (a) as well as against aerobic 
(b) and anaerobic (c) microorganisms following three-day (3 d) biofilm formation. The bacterial counts of the 
following treatment groups are demonstrated for two-hour- and three-day-old oral biofilms: untreated and H. 
perforatum-treated negative controls, 0.2% CHX-treated positive control, aPDT after rinsing off H. perforatum, 
and aPDT without rinsing off H. perforatum. The CFUs are presented on a log10 scale per square centimeter 
(log10/cm2). The p-values (t test) of the significantly different data are marked on the graphs.
Figure 5. Relative distribution among the volunteers and total distribution (in percentages) of bacterial species 
among six probands after two-hour (2 h) initial adhesion following aPDT using VIS + wIRA and H. perforatum. 
Graph A depicts the bacterial composition of the untreated negative controls after initial adhesion. Graph B 
shows the bacterial diversity after aPDT against initially adhered bacteria. Consistent color coding was used for 
the study participants and bacterial species, as indicated by the schemes at the right of panels, respectively.
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Shift of bacterial community composition after apDt application to the mature oral bio-
film. Interestingly, after aPDT with VIS + wIRA in the presence of H. perforatum, the total microbial load of 
the biofilms was reduced by 100%. The microbial richness after pre-treatment with H. perforatum and aPDT with 
VIS + wIRA and the bacterial composition of the controls (negative: untreated, positive: treatment with 0.2% 
CHX) are illustrated in Figs. 8A–C, 6B and 7C–E. Regarding the microbial richness within the mature biofilms, 
the untreated control, the CHX-treated positive control and the aPDT-treated biofilms comprised 35, 27, and 30 
different bacterial species, respectively.
The microbial community in the negative control group (Fig. 8A) was predominated (24%) by six differ-
ent streptococcal species (S. mitis/oralis, 11%; S. sanguinis/parasanguinis, 7%; S. infantis, 4%; S. gordonii, 2%). 
Different species of the genera Rothia (R. dentocariosa, R. aeria, R. mucilaginosa), Neisseria (N. flavescens/per-
flava, N. mucosa/macacae, N. cinerea), Veillonella (V. parvula/dispar) and Granulicatella (G. adiacens, G. elegans) 
were found in 15%, 14%, 8% and 8% of the isolated bacteria, respectively. The percentages of all other recovered 
species mainly belonging to the genera Capnocytophaga, Campylobacter, Gemella (G. sanguinis, G. haemolysans) 
and Actinomyces (A. odontolyticus, A. oris) ranged from 3 to 7%.
In the positive control (Fig. 8B), the microbial richness was reduced to 27 species after treatment with 0.2% 
CHX. Although the counts of Eikenella corrodens, S. gordonii, and R. dentocariosa increased after the CHX 
Figure 6. Heatmap presenting the absolute distribution (in log10/cm2) of bacterial species among six study 
probands after two-hour (2 h) initial adhesion and three-day (3 d) biofilm formation following aPDT using 
VIS + wIRA and H. perforatum. The photodynamic efficiency against oral microorganisms after initial adhesion 
and three-day biofilm formation is demonstrated in panels A and B, respectively. The bacterial composition 
of the following treatment groups is demonstrated for two-hour- and three-day old oral biofilms: untreated 
negative control, 0.2% CHX-treated positive control, aPDT after rinsing off H. perforatum, aPDT without 
rinsing off H. perforatum. Proband numbers for each treatment group (n = 6) are shown in columns and 
variables (bacterial species and genera) are shown in rows. The variations in the colors depicted on the color 
scale bars on the right indicate how data values change from very low to extremely high.
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treatment, all of the other bacterial counts within the positive control decreased. A total of ten species could not 
be detected after treatment with CHX, whereas Abiotropha defectiva and Atopobium parvulum could only be 
detected after the treatment with CHX.
As depicted in Fig. 8C, the aPDT with VIS + wIRA and H. perforatum – which was rinsed prior to aPDT 
– reduced the number of viable bacterial species from 35 to 30. The aPDT-treated biofilm mainly comprised 
17% Streptococcus spp. (S. mitis/oralis, 5%; S. sanguinis/parasanguinis, 4%; S. australis, 4%; S. gordonii, 4%), 
13% Neisseria spp. (N. flavescens/perflava, 4%; N. mucosa/macacae, 4%) and 12% Rothia spp. (R. mucilagi-
nosa, 5%; R. dentocariosa, 4%; R. aeria, 3%). The percentages of the other detected genera such as Haemophilus, 
Campylobacter, Gemella, Veillonella, Capnocytophaga and Actinomyces varied from 4 to 5%. A total of 15 out of 
the 30 recovered bacterial species were found to decrease in number. Nine species – Haemophilus parahaemolyt-
icus, N. cinerea, Cardiobacterium hominis, Selenomonas noxia, Lachnoanaerobaculum orale, Fusobacterium spp., 
S. infantis, G. elegans and G. haemolysans – completely disappeared after the aPDT treatment with H. perforatum, 
whereas S. australis, Veillonella spp., Atopobium parvulum and Lautropia mirabilis only appeared after the photo-
dynamic application of H. perforatum.
Regarding the species distribution among the probands, S. mitis/oralis, R. mucillaginosa and V. parvula/dispar 
were detected in all six volunteers of the untreated control group, with a total distribution ranging from 8 to 11%. 
Capnocytophaga spp. (7%) was detected in five volunteers, whereas the other bacterial species were recovered 
from 1–4 probands. After the aPDT treatment, S. mitis/oralis, S. sanguinis/parasanguinis, R. mucillaginosa, V. par-
vula/dispar and Campylobacter concisus were detected in all six volunteers, with a total distribution ranging from 
4 to 11%. All other species appeared in 1–5 volunteers and ranged from 1 to 4%. After aPDT treatment, a total 
of eight aerobic and three anaerobic microorganisms increased in their relative distribution compared with the 
CHX treatment, where only three aerobic microorganisms increased. In terms of the new appearance of bacteria 
after the aPDT with H. perforatum, two aerobic and two anaerobic bacteria emerged compared with the CHX 
treatment, where only one aerobic and one anaerobic bacteria appeared.
Discussion
The present study has established an effective method for microbial photoinactivation combining VIS + wIRA 
with the natural photosensitizing agent H. perforatum to treat in situ-formed initial and mature oral biofilms for 
the first time. The aPDT combining VIS + wIRA and photosensitizing agents such as TB and Ce6 was reported to 
successfully photoinactivate oral pathogenic microorganisms situated even in the deepest niches of in situ suprag-
ingival and subgingival biofilms in earlier own reports14,15,17,33. In an in vitro study investigating the effectiveness 
of H. hypericum-mediated aPDT on E. faecalis culture in planktonic form and biofilm, a significant microbial 
Figure 7. Pie charts demonstrating the total distribution (in percentages) of bacterial genera among six 
probands after two-hour (2 h) initial adhesion and three-day (3 d) biofilm formation following aPDT using 
VIS + wIRA and H. perforatum. Graph A depicts the bacterial composition of the untreated negative controls 
after initial adhesion. Graph B shows the bacterial diversity after aPDT against initial biofilms. Graphs C–E 
show the bacterial composition of three-day old biofilms divided into the following groups: the untreated 
negative control (C), after treatment with 0.2% CHX (D), and after aPDT (E) with VIS + wIRA and H. 
perforatum (was rinsed off prior to aPDT). Consistent color coding was used for the bacterial genera, as 
indicated by the schemes at the right of panels A–E, respectively.
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reduction of up to 5 log counts was detected34. The innovative contribution of this study is that, to the best of our 
knowledge, H. perforatum – widely known for its anti-depressant properties – is here studied for the first time in 
combination with VIS + wIRA as a light source to treat in situ oral biofilms35–38.
For an effective aPDT light source, visible light (VIS) with an accessory orange filter within the range of 
570–780 nm was combined with water-filtered infrared-A (wIRA) to accentuate the amount of infrared-A radi-
ation within the range of 780–1400 nm39. Since PS excitation is only possible within the range of VIS, the use of 
wIRA alone would not have yielded the desired photodynamic outcomes39. The advantages of using VIS + wIRA 
contrary to VIS alone have already been outlined in the literature9. The emission of energy in the form of light 
results in electron transfer reactions between the substrate and the PS, with the latter entering an electronically 
excited state40. The leading antimicrobial effect of aPDT is the subsequent production in elevated rates of reactive 
oxygen species (ROS) such as superoxide ion (O2−), hydrogen peroxide (H2O2) and free hydroxyl radicals (.HO), 
all yielded via Type I mechanisms41. In a Type II reaction, single oxygen radicals (1O2) are yielded after the reac-
tion of triplet state PS and oxygen (O2)42.
Due to the short lifetime of ROS (about 10–320 ns), their diffusion after using conventional light sources 
(laser and non-laser) is limited and thus the direct aPDT-induced damage remains localized to the PS-infiltrated 
area43. VIS + wIRA also allows for the release of the protective protein ferritin44 to prevent cell destruction. The 
high safety of VIS + wIRA radiators can be guaranteed for treatment times of up to 30 min45, although 5 minutes 
proved to be a potent average aPDT duration in our report with a focus on daily clinical use. To facilitate a better 
distribution of photosensitizer within the bacterial cells and to achieve clinically meaningful treatment times, the 
biofilms were pre-exposed to H. perforatum for 2 min in the dark. In a systematic review, Fumes et al. described 
pre-irradiation times for methylene blue (MB) between 1 and 15 minutes, with optimal outcomes between 5 and 
15 min46. However, there is no published data on the pre-irradiation incubation of H. perforatum, which exhibits 
enhanced cell penetration when diluted in ethanol47. Finally, VIS + wIRA raises levels of physiological activity of 
the regulatory enzyme cytochrome c oxidase with absorption maxima at 620, 680, 760 and 825 nm48.
Figure 8. Relative distribution among the volunteers and total distribution (in percentages) of bacterial 
species among six probands after three-day (3 d) biofilm formation following aPDT using VIS + wIRA and 
H. perforatum. Graphs A–C demonstrate the bacterial composition of three-day old biofilms divided into the 
following groups: the untreated negative control (A), after treatment with 0.2% CHX (B), and after aPDT (C) 
with VIS + wIRA and H. perforatum (was rinsed off prior to aPDT). Consistent color coding was used for the 
study participants and bacterial species, as indicated by the schemes at the right of panels A–C, respectively.
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Due to its numerous advantageous properties, H. perforatum constitutes a multipurpose plant49 and is con-
sidered one of the most well-known natural photosensitizers in different medical fields50. Interestingly, H. perfo-
ratum has proven extremely effective in the treatment of non-melanoma skin cancer as well as other dermal and 
internal cancer species18,51,52. Besides its excellent anti-oxidant and anti-inflammatory effects53, H. perforatum has 
been successfully applied in dentistry for the pain management of trigeminal neuralgia54. Furthermore, hypericin 
and hyperforin – the main components of H. perforatum – are responsible for enhanced anti-bacterial activity 
against Gram-positive and Gram-negative microorganisms in both planktonic and biofilm forms55. As a result of 
its beneficial features, H. perforatum can be integrated in a greater number of clinical photoinactivation protocols 
compared with Ce6, TB, ICG and MB18,35,37,56. When administered systematically, H. perforatum inevitably inter-
acts with several cytochrome enzymes, inducing lower plasma levels of anti-cancer agents or other medicines57. 
Nevertheless, local application of H. perforatum is associated with fewer side effects regarding cytotoxicity and 
cross-reactivity with other medicaments58. Even after the combined oral application of H. perforatum using both 
a single- and double-dose of UV radiation, visible light, and solar-simulated radiation, no significant pathogenic 
alterations could be detected at erythema threshold levels59. However, a recent report highlighted the increase 
of round fibroblastic cells, which indicated high cytotoxicity in concentrations of H. perforatum higher than 
10–50 mg/ml60.
Solvent extraction is the most common means of extracting Hypericum from the flowers of H. perforatum 
(St John’s Wort). Solvents include methanol, ethanol, ethyl acetate and acetone. Scientific studies indicate when 
using extraction solvents containing more than 50% ethanol or methanol in water the content of the flavonoids 
in particular Hypericum and Hypericin in the extracts is similar independent of the extraction solvent61. H. 
perforatum extracts are often purified by removing the solvent and then dried into powders prior to commercial 
sale. This project required a crude liquid extract which contained the solvent for further clinical trials. For this 
reason methanol, ethyl acetate and acetone were not used as the solvent for the extraction of Hypericum due to 
the potential toxicity of the solvent in the crude extract. In order to extract bioactive constituents from H. per-
foratum, organic solvents were preferred, as ethanolic H. perforatum extracts showed the highest anti-bacterial 
potential against diverse Gram-positive and Gram-negative bacteria37. In the literature, other H. perforatum 
hydroethanolic extracts such as tinctures with a high alcohol content ranging from 45 to 50% have been widely 
used in complementary medicine62. In a recent report, 60% or above of ethanol was utilized to obtain the high-
est yields of lipophilic hyperforin63. However, the use of 100% (absolute) ethanol led to a reduction of specific 
hydrophilic components such as flavonoids18. Since bacteria in biofilms are more resistant to antimicrobials than 
their planktonic counterparts, we did not expect a significant decrease of biofilm viability after its exposure to 
16% alcohol solution for seven minutes as detected by CFU. To confirm our assumption, we ran primary exper-
iments resulting in no significant differences in CFUs between biofilms after 7-min treatment with 16% alcohol 
and the untreated control (Supplementary Fig. S1). Hence, a bactericidal effect of alcohol at the tested concen-
tration can be excluded. It is recommended that future studies examine the role of alcohol in detail using live 
dead staining along with CFU determination. A bactericidal effect of the alcohol on the mature oral biofilm is 
not possible after an incubation time of seven minutes as detected by the CFU64. The authors reported that an 
alcohol concentration of 30% and incubation time of 8 hours were required to detect bactericidal effects against 
biofilms formed by Klebsiella pneumoniae and Pseudomonas aeruginosa after 40 hours. It should be taken into 
consideration that mature multispecies oral biofilms are more resistant to alcohol than mono-species biofilms 
tested in the aforementioned study. Ultrasonication (70% amplitude) using a digital ultrasonic bath (Sonorex 
Digital 10 P from Bandelin, Berlin, Germany) was applied to dissolve adherent bacteria from substratum. This 
ultrasonication power treatment for 4 min on ice was highly effective in killing adherent anaerobic bacteria such 
as Porphyromonas gingivalis, as reported in a previous own study65.
In a recent study, a promoting effect for periodontal healing was found for photosensitizer methylene blue 
(MB), which was dissolved in 20% ethanol during aPDT13,47. Presumably, this can be attributed to the up to 
5-fold increase in survival time of ROS66. Another study showed that 20–30% ethanol is necessary to prevent the 
resuscitation of multispecies biofilms67. This supportive antimicrobial effect of ethanol can be attributed to the 
manipulation of the bacterial membrane and the denaturation of proteins68. In earlier reports, it has been shown 
that lipophilic photosensitizers are much more efficient than hydrophilic ones with the same ROS supply69,70. 
In contrast to conventional photosensitizing agents such as TB, ICG, MB and Ce6, the high anti-bacterial effi-
ciency of H. perforatum extract cannot be attributed to mechanisms involving only one specific pure substance. 
Interestingly, synergetic interactions between three main constituents – namely hypericin, pseudohyperin and 
hyperforin – are responsible for the high antimicrobial potential of H. perforatum26,27,71,72. Nevertheless, their 
exact mechanism of action remains unknown26,27. Further studies are necessary to determine the synergistic 
potential of specific H. perforatum components.
Obtaining an in situ oral biofilm enabled us to conduct the assays under more realistic experimental condi-
tions, as already described in previous own reports73,74. Bovine enamel slabs (BES) represent a favorable habitat 
for the adhesion of oral microorganisms which is physicochemically similar to human tooth surfaces75. Due to 
substantial differences in biofilm composition and architecture between artificial and natural tooth surfaces, the 
tests were conducted solely on the latter.
About 700 oral bacterial species are estimated as residing within the oral cavity, of which only 50% have been 
cultivated thus far76,77. Subsequently, the plate count technique as well as the culture media favor the growth of 
certain types of bacteria78. Nevertheless, CFU remains the most widely used gold standard method for the quan-
tification of viable bacteria79, which is the focus of this study.
The application of aPDT completely inhibited bacterial growth when the initial and three-day-old biofilms 
were photodynamically treated in the presence of H. perforatum.
This is a very interesting finding, indicating the high bactericidal potential of H. perforatum-mediated aPDT 
compared with aPDT employing other photosensitizers in previous reports17,76,77,80. The presence of extracellular 
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polymeric substances (EPS) within the oral biofilm and the chemical composition of the photosensitizers and cell 
envelope in Gram-positive and Gram-negative bacteria are crucial parameters that can define the degree of pho-
tosensitizer diffusion in biofilm biomass. In order to investigate the exact depth of penetration as well as whether 
non-viable bacteria can survive this procedure, further studies are necessary. Another critical aspect is the possi-
bility that aPDT favors the survival of resistant bacteria. Although there are no relevant studies in the literature, 
even if this assumption was true, the application of low concentrations of photosensitizer would carry the same 
risk of creating a resistance-prone microbial community as treatment with low doses of CHX or antibiotics1,2,81,82.
In this study, we have shown that treatment with CHX as well as aPDT after rinsing off H. perforatum reduced 
the number of viable bacterial species, albeit not significantly. Nevertheless, the shift to a predominately aerobic 
environment after aPDT holds strong importance as it implies the presence of a high alteration potential of H. 
perforatum-mediated aPDT on biofilm synthesis. Caries and periodontitis are biofilm-associated oral infections 
that can be controlled after favorably changing the composition of the pathogenic microbial ecosystems into 
healthier microbial communities23,77,83,84. Ascertaining which alterations of the biofilm composition are advanta-
geous for the development of a ‘healthy’ microbial environment constitutes an alternative treatment approach in 
case the complete mechanical removal of the biofilm poses clinical challenges and should be the focus of future 
investigations85–87.
Interestingly, H. perforatum had the highest efficiency as a photosensitizer when it was not rinsed prior to 
aPDT. This could be explained by the fact that the prolonged contact of H. perforatum with the oral biofilm 
could facilitate the maximum penetration of the biofilm through diffusion or endocytosis4. Taking the short life-
time of the ROS (about 10–320 ns) into consideration, the time extension of the synergistic interaction between 
diverse components in H. perforatum total extract and biofilm constituents such as EPS may be crucial for the 
aPDT-induced antimicrobial efficacy17,21. The highest antimicrobial effect can be achieved when the photosensi-
tizer remains as close as possible to the targeted bacteria43,88.
To sum up, this study has shown that H. perforatum as a PS in combination with VIS and wIRA has a strong 
ability to eradicate in situ oral biofilms. The null hypothesis was rejected. The results of the study highlight the 
already-known positive effects of aPDT in the dental field and introduce H. perforatum as a potent photosensi-
tizer for clinical use.
Material and Methods
Selection of study volunteers and test samples. After the review and approval of the study protocol 
by the Ethics Committee of the University of Freiburg (Nr. 91/13), six healthy volunteers between the age of 24 
and 44 were selected and gave their written informed consent to participate in this study. All experiments and 
data collection were performed in accordance with relevant institutional and national guidelines and regulations. 
Individual clinical oral examinations were performed for each volunteer prior to study enrollment. Thus, the 
salivary flow rate was estimated in the range of 1.2 ± 0.4 ml/min, and the lactate production rate was measured 
at 2.7 ± 0.6 (scale from 1 to 9). The mean values for decayed, missing, filled teeth (DMFT) ranged between 0 and 
717,89. A complete dentition allowing for sufficient room for the slabs served as a requirement for the stable main-
tenance of the splint. The exclusion criteria included severe systematic disease, diseases of the salivary glands, 
carious lesions or periodontal disease, pregnancy or lactation, and use of antibiotics or local antimicrobial mouth 
rinses e.g. chlorhexidine (CHX) within the last 30 days17,80.
In order to perform the experiment, BES were obtained from freshly slaughtered two-year-old cattle (diame-
ter, 5 mm; surface area, 19.63 mm²; height, 1 mm). Before extracting their teeth, the cattle were examined for the 
absence of bovine spo.pngorm encephalopathy (BSE) using an IDEXX labor index diagnostic kit (Ludwigsburg, 
Germany). The BES were fixed into plastic holders yielding parallel surfaces with an average height of 1 mm and 
were then polished using wet sandpaper with increasing corn sizes from 250 to 40,000 grits in a special polishing 
machine (Knuth-Rothor-3; Streuers, Willich, Germany) to yield a smooth surface. To guarantee consistency and 
thereby confirm the presence of intact enamel with clean polished surfaces a light microscope (Wild M3Z, Leica 
GmbH, Wetzlar, Germany) was used, and the BES were finally disinfected as previously described80. In brief, the 
first disinfection step was ultrasonication of the BES for 3 minutes with NaOCl (3%), followed by air drying to 
remove the superficial smear layer. For additional disinfection, 70% ethanol was subsequently applied for three 
minutes under ultrasonication. In the second disinfection step, BES were fixed to acrylic oral appliances described 
elsewhere and both BES and the devices were ultrasonicated twice in double-distilled water for ten minutes to 
allow the removal of residual NaOCl. Before the experiments, the BES-loaded oral devices were stored in distilled 
water for at least 24 hours to hydrate17.
Individual upper jaw acrylic devices were constructed with a total of six round openings at the interdental 
area between the upper premolars and molars, three on each side, respectively. The openings were sufficiently 
wide and deep to allow for the insertion of BES without interaction with the mucosa (Fig. 1). In order to fix the 
BES into the openings, an A silicon compound (Panasil initial contact X-Light, Kettenbach GmbH & Co. KG, 
Eschenburg, Germany) was used. In order to ensure that only BES surfaces were exposed to the oral cavity and 
that no unwanted contact took place between the buccal mucosa or the tongue and the BES, the BES margins were 
fully covered with silicon. In order to yield a sufficient number of biofilm samples for the aPDT assays, each vol-
unteer carried the appliances loaded with a total of twelve BES twice, for two hours and three days, respectively.
Radiation source and photosensitizer. The obtained biofilm samples were illuminated by broadband 
VIS + wIRA radiator (Hydrosun 750 FS, Hydrosun Medizintechnik GmbH, Müllheim, Germany) contain-
ing a 7 mm water cuvette14,17. For the absorption of the infrared-B and -C wavelengths emitted by the halogen 
lamp, an accessory water filter (dimensions: length: 28 cm, width: 27 cm, height: 28 cm) using 750 W (volt-
age: 230 V, 50–60 Hz) was inserted into the light path. The radiator also included an orange filter, namely BTE 
31, with a diameter of 10 cm and an efficiency level of 200 mW/cm². The BTE 31 filter enabled more than a 
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doubled-weighted efficient integral illumination with reference to the absorption spectrum of protoporphyrin 
IX. In order to prevent superficial overheating, the absorption bands 944 and 1180 nm were also filtered. The total 
spectrum of the water-filtered absorption ranged from 570 nm to 1400 nm, with local minima at around 970 nm, 
1200 nm and 1430 nm, respectively90. The total amount of unweighted (absolute) radiation applied to the biofilms 
for 5 minutes equaled 200 mW cm−2 VIS + wIRA, which comprised 48 mW cm−2 VIS and 152 mW cm−2 wIRA. 
This broad-spectrum light source provided optimal absorption for the tested photosensitizer, namely H. perfora-
tum ethanol (15.8%) extract (St. John’s Wort, Quality Herbal Extracts, Cooranbong, Australia). Pseudohypericin 
– the main component of H. perforatum – can be activated within the UVA (and UVA1) visible absorption range, 
while absorption peaks are mainly exhibited at red wavelengths (570–700 nm)91. The visible absorption max-
imum (λ max) of H. perforatum is 598 nm92. For the assays, H. perforatum extract was diluted in 0.9% saline 
(NaCl) to a final concentration of 32 mg ml−1 and a final alcohol concentration of 15.8% (v: v). Prior to use, the 
original extract solution was stored in a light safety glass at 4 °C in the dark for up to fourteen days to block any 
light-induced photochemical attenuation.
extraction of H. perforatum. Wild-growing Hypericum perforatum was harvested during the flower-
ing phase. The herbaceous material was dried, cut, and stored until further processing. The crude extract was 
produced by percolation using 95% aqueous ethanol as a solvent (menstruum). The milled herbal material was 
moistened with some of the menstruum and packed firmly in a cylindrical percolator. Additional menstruum 
was added to the percolator and the herb was allowed to macerate for 24 hours before the percolation was com-
menced. Percolation comprised the slow passage of menstruum through the column of drug. The maceration 
and percolation were performed at 30 °C. The percolation was repeated until the material was exhausted. The 
extractions were combined and the solvent recovered under vacuum evaporation to yield a final ratio of one part 
drug per one part solvent (1: 1).
Ultra-high-performance liquid chromatography coupled with high resolution mass spectrom-
etry (UpLc-HRMS). The H. perforatum extract was submitted to UPLC-HRMS/MS analysis on an AQUITY 
system (Waters) connected to an LTQ-OrbitrapR XL hybrid mass spectrometer (Thermo Scientific) equipped 
with an electrospray ionization (ESI) source and operated in negative mode. A UPLC separation gradient was 
developed to efficiently resolve all compounds for a qualitative analysis. The flow rate was set at 0.4 mL/min and 
the solvent system was (A) water 0.1% formic acid and (B) acetonitrile 0.1% formic acid. The elution program 
was 2% B for 2 minutes, 100% B for 18 minutes, and held for 2 minutes. After returning to 2% B for 1 minute, 
column equilibration was performed for 4 minutes at the end of the run. The injection volume was set to 10 μL 
and samples were injected at 0.2 mg/mL in water-acetonitrile solution (1:1) on a Fortis, C18 (100 × 2.1 mm i.d, 1.7 
μm particle size). The HRMS and HRMS/MS data were acquired in negative mode over a 100–1000 m/z range. 
The MS profile was recorded in full-scan mode (scan time = 1 micro scans and maximum inject time = 500 ms). 
The ESI conditions were as follows: capillary temperature 320 °C; capillary voltage −40 V; tube lens −120 V; ESI 
voltage 2.7 kV. Nitrogen was used as sheath gas (40 Au) and auxiliary gas (8 Au). For the HRMS/MS acquisitions, 
a data-dependent method including the detection (full scan) and fragmentation of the three most intense peaks 
per scan was used. The mass resolving power was 30,000 for both levels and the normalized collision energy 
(CID) in the ion trap was set to 35.0% (q = 0.25) for the HRMS/MS experiments. Chromatographic and spec-
trometric features were used for identifying extracts constituents such as retention time (Rt), polarity, accurate 
m/z, proposed elemental composition (EC) and ring double bond equivalent (RDBeq) values as well as HRMS/
MS spectra and derived fragmentation motifs. The raw data were acquired and processed using XCalibur 2.2.4 
software from Thermo Scientific.
apDt protocol for in situ oral biofilms. Each participant twice carried an individual BES-loaded upper 
jaw acrylic device for the assays involving the initial adhesion (two hours) and biofilm formation (three days). 
After obtaining the in situ biofilms, the devices were removed from the oral cavity. Subsequently, BES were 
detached using sterile tweezers and a dental probe to avoid disturbing the intact in situ biofilms. Each of the BES 
was rinsed for 30 seconds with sterile 0.9% NaCl to ensure the displacement of non-adherent bacteria. One BES 
served as a positive control and was treated with 0.2% CHX, while another two BES treated with 0.9% NaCl and H. 
perforatum without aPDT were used as negative controls. One biofilm-covered BES was preincubated in H. perfo-
ratum, which was rinsed off for 30 seconds with 1 ml 0.9% NaCl prior to aPDT ex vivo using VIS + wIRA to allow 
for optimal depth of the irradiation. The remaining BES was also preincubated in H. perforatum, which remained 
during aPDT ex vivo using VIS + wIRA. The preincubation time for each BES in H. perforatum at a concentra-
tion of 32 mg ml−1 was two minutes in multiwell plates (24-well plate, Greiner bio-one GmbH, Frickenhausen, 
Germany) in the dark as described elsewhere17, while the irradiation by VIS + wIRA lasted five minutes at 37 °C 
(Fig. 2). After aPDT, the BES were inserted into multiwell plates with 1 ml 0.9% NaCl and the quantification and 
identification of adherent microorganisms were performed by the CFU and with MALDI-TOF, respectively. The 
activity of the photosensitizer remained stable for six months of storage at low temperature (3 °C) in the dark 
using a light-tight bottle. The participants carried the BES twice for 72 h and 2 h, respectively.
Quantification of the adherent oral microorganisms within biofilms. The margins and the bottom 
dentine surfaces of the biofilm-loaded BES were brushed down with small sterile foam pellets (Voco GmbH, 
Cuxhaven, Germany) to displace non-adherent microorganisms. Subsequently, the BES were washed with 0.9% 
NaCl for at least 10 seconds to remove the remaining non-attached microorganisms. For the dilution series, each 
treated BES was transferred into Eppendorf tubes (Eppendorf GmbH, Wesseling-Berzdorf, Germany) containing 
1 ml 0.9% NaCl, ultrasonicated for 3 minutes in 1 ml NaCl on ice and finally vortexed for at least 30 seconds to dis-
lodge the biofilm microorganisms from the BES surface. Subsequently, the suspensions untreated BES (negative 
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control), CHX-treated BES (positive control) and all aPDT-treated BES were diluted from up to 1:103 (initial 
biofilm) and up to 1:106 (mature biofilm) in 0.9% NaCl. From each dilution series of the differently treated BES 
three different dilutions were plated on separate agar plates. Thereafter, the microorganisms were cultivated and 
identified as previously described93. In brief, for the CFU estimation of the aerobic and facultative anaerobic bac-
teria Columbia blood agar plates (CBA; Becton, Dickinson, Heidelberg, Germany) were used at 37 °C and 5% CO2 
for 3–5 days. Anaerobic bacteria were cultivated on yeast-cystein blood agar plates (HCB; Becton, Dickinson, 
Heidelberg, Germany) and incubated for ten days at 37 °C (anaerobic chamber; Genbox bioMérieux SA, Marcy 
l’Etoile, France). The CFU were finally counted per ml of the original suspension using Gel Doc EQ universal 
hood (Bio-Rad Life Science Group, Hercules, CA, USA). Each measurement was repeated, and the surviving 
bacteria were counted by eye if necessary.
Identification of the adherent oral microorganisms within biofilms. The recovered bacterial colo-
nies were sub-cultivated to yield pure cultures. In order to identify certain bacterial species, MALDI-TOF analysis 
in a MALDI Biotyper Microflex LT (Maldi Biotyper, Bruker Daltonik GmbH, Bremen, Germany) was applied. 
The Biotyper 3.0 Software obtained mass spectra according to the manufacturer’s instructions and compared 
the acquired spectra with a total of 3,740 spectra of the reference database (representing 319 genera and 1,946 
species). The resulting similarities were illustrated by a log score indicating the species level with values ≥ 2.0, 
whereas values ≥ 1.7 represented identification at the genus level. For values < 1.7, the yielded spectrum exhibited 
no significant similarity to any database spectrum. The analysis was repeated if the identification of the species 
could not be confirmed. Moreover, universal bacterial PCR was performed as a supplementary method to iden-
tify the surviving oral microorganisms. In the presence of MALDI-TOF scores < 1.7, the following primers were 
applied: TP16U1: 5′-AGAGTTTGATCMTGGCTCAG-3′ and RT16U6: 5′-ATTGTAGCACGTGTGTNCCCC-3′ 
followed by sequencing on a 3130 Genetic Analyzer (Applied Biosystems, Life Technologies GmbH, Darmstadt, 
Germany).
Statistical analysis. The effects of aPDT using VIS + wIRA and H. perforatum as a photosensitizer were 
calculated in a detailed evaluation for all six volunteers. For descriptive analysis, mean and standard deviations 
were computed. For graphical demonstration of the results, boxplots were used. Diagrams that demonstrated the 
log10 scale per square centimeter (log10/cm2) were selected to visualize the viable bacteria stratified to biofilm age 
(initial/mature) and type of microorganism (aerobic/anaerobic). A Friedman test was used to depict the differ-
ences between the aPDT-treated groups and the controls. Because a nonparametric test lacks sufficient power due 
to the small number of cases, paired t-tests with Bonferroni correction (multiple testing) were used for pairwise 
tests of differences among biofilms. Scheffé’s method was applied to correct the multiple testing errors through the 
adjustment of p-values. The statistical analysis was performed using STATA 14.
Data availability
All data generated or analyzed during this study are included in this published article.
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